Jim Coy Email & Phone Number

Blue Bell, Pennsylvania, United States

Furlong, Pa

Managing Partner & Executive Consultant to senior executives interested in defining and executing operational strategies to capture commercial opportunities. Service offerings include:► Interim and Fractional Executive► Business Development, inclusive of Due Diligence and Post-Deal Integration► Business Partnerships & Alliances► Third-Party Management / Vendor & Supplier Contract and Performance Management► Advisory & Program / Project Management► Change Management

Upper Gwynedd, Pa

Upper Gwynedd, Pa

► Joined as Head of the SBO and a Member of the Global Regulatory, Compliance, and Safety Leadership Team, a 2,000+ employee strong organization.► Transitioned to new role managing Supplier Operations where more than 13k filings were submitted, right the first time, to Global Health Authorities in 2022, making up more than 85% of Merck’s global submissions.► Restructured the SBO as part of an organizational realignment, impacting GxP documentation, program management, resource management, and business analytics.► Established new Ways of Working across organizational silos as the company spun-off legacy assets and key resources to Organon & Company, totaling 60 products earning $4.5B in revenue.► Leveraged the capabilities of the team to inform Senior Leaders and drive data-driven decision-making.

South Plainfield, Pa

► Full P&L responsibility. Accountable for financial / operational success of the company’s contract manufacturing business, while also co-leading a sales process for its two remaining sites producing multiple dosage forms and employing nearly 450 employees.► Continued to achieve customer service levels / contractual requirements in a cultural environment where employees were facing possible layoff / sale.► Successfully co-led the divestment of a leading U.S. site producing Liquids, Creams, and Ointments located in Lincolnton, NC, while also actively co-leading the sales process to divest a site producing LCO and Oral Solid Dose in Sellersville, PA.

South Plainfield, Pa

► Executive leadership expanded the role to bring strategic focus, P&L ownership, to more than 30+ new / established commercial partnerships that produced more than 50% of total revenue.► Generated multiple new partnerships (profit, ANDA acquisitions & in/out-licensing deals), managing all aspects of the deals from performing the due diligence, contracting, integration to post-deal alliance management.► Co-led, defined, and executed a carveout of the company’s dermatological business, including a production site in South Plainfield, NJ, with 300+ unionized employees and associated rights to products and agreements.

South Plainfield, Pa

► Worked closely with Owners / Leadership. Led and managed transformative initiatives strategic to the company’s growth targets. Served as the company’s representative to the Federal Trade Commission (FTC).► Assessed and negotiated deals / partnerships that drove strategic corporate growth and partnered with operations leadership to capture the deal value via integration / execution into the company.► Led and managed the acquisition and subsequent integration of two production facilities (Lincolnton, NC, and Sellersville, PA) inclusive of asset / product, supply, and transition service agreements, tripling the footprint of the company and expanding access to new dosage forms.► Acquired via divestiture and subsequently launched generic prescription products.► Established, led, and managed a high-performing, cross-functional team of experts integral to post-deal success from the due diligence phase through integration.

South Plainfield, Pa

► Recruited to establish organizational structures to support company’s growth initiatives and define / implement a strategic model that included the maturation of process, talent, and systems, while also speedily improving customer service and the company’s safety stock position.► Implemented S&OP process and managed all related function's operations including planning, procurement, warehousing, distribution & logistics, third-party (vendor) and alliance (commercial partners) management, and new product launch.► Organized operations campaigns that achieved targeted safety stock levels for all Rx SKUs within the first six months of employment. Led the rationalization of OTC and private label products and implemented procedures to actively manage 3rd party suppliers.► Established the company’s first formalized stage-gate process to govern new product introductions.► Scaled distribution operations through the identification, contracting, and transition of in-house logistics (ambient, controlled, and clinical) to multiple 3PLs, improving ability to support company growth with limited investment. Also scaled production capacity by modernizing production Suite’s equipment, processes, controls. ► Recognized by customers for outstanding service and received multiple awards for Supplier Excellence including the Cardinal Health Supply Chain Excellence Award.

North Wales, Pa

► Member of a management team that oversaw supply chain, distribution, and logistics for commercial / technical operations. In addition, led a team of more than 25 employees responsible for daily operations and continuous improvement activities resulting in nearly 100% customer service.► Accountable for 30+ concurrent strategic initiatives and >$100M in capital investment, assuring continuity of distribution operations, inventory optimization, compliance with serialization laws, and Lean transformation.► Managed the design, build and automation of 3 warehousing / distribution facilities totaling 600k sq ft., whereby at that time Teva product made up one in seven prescriptions dispensed by U.S. pharmacies.

North Wales, Pa

► Reported directly to the senior management team and served as the primary integration expert leveraging due diligence and team expertise to achieve intended strategic objectives.► Executed the integration of the $3.4B purchase of Sicor in 2004, $7.4B purchase of Ivax in 2006, $7.5B purchase of Barr Pharmaceuticals in 2008, and $6.8B purchase of Cephalon in 2011.► Enabled the quick absorption of new strategic acquisitions and met Wall Street and customer expectations.► Gained the unique opportunity to acquire knowledge of each Company’s business / dosage forms, for example, injectables, solids, semi-solid, oral liquid, suppository, and medical devices.

North Wales, Pa

► Responsible for risk and controls management, advisory, consulting, and audit services within Teva North America, including its subsidiaries in the U.S. and Canada. Managed a team of 5 auditors.

Philadelphia, Pa

Philadelphia, Pa